Streetbeat News

Stock Prices

MIRA

Mira Pharmaceuticals is advancing its preclinical studies using Ketamir-2 towards clinical development, indicating progress in their drug development pipeline.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:11 pm

JNJ

Johnson & Johnson announced that its Phase 3 QUASAR Maintenance Study for TREMFYA in treating ulcerative colitis met its primary and all major secondary endpoints, showing significant rates of clinical and endoscopic remission.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:11 pm

AKTS

QRVO

On May 17, 2024, Qorvo won a jury verdict against Akoustis Technologies in a trade secret misappropriation and patent infringement case, awarding Qorvo $38.6M in damages. Akoustis plans to challenge the verdict, but the financial uncertainties could impact its ability to raise capital and may necessitate operational cutbacks or bankruptcy protection.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:10 pm

FFIE

GTBP

MMV

WIX

Wix.com Ltd. (NASDAQ:WIX) shares rose 6.9% in pre-market trading after the company posted better-than-expected Q1 earnings and raised its 2024 forecast. Other notable pre-market movers include MultiMetaVerse Holdings Limited (NASDAQ:MMV), Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE), and GT Biopharma, Inc. (NASDAQ:GTBP).

Portfolio Pulse from Avi Kapoor

May 20, 2024 | 12:09 pm

NKGN

NKGen Biotech shares are trading higher after the company's SNK01 NK Cell Therapy was cleared to begin a Phase 2 trial in Alzheimer's disease.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:08 pm

ALLR

Allarity Therapeutics has regained compliance with Nasdaq's listing requirements, ensuring its continued presence on the exchange.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:07 pm

IKT

Inhibikase Therapeutics has announced a $4.0 million registered direct offering and warrant inducement involving 1,672,452 shares of common stock and 1,672,452 unregistered Class B warrants at a combined purchase price of $1.68 per share and warrant.

Portfolio Pulse from Benzinga Newsdesk

May 20, 2024 | 12:07 pm

BNED

EJH

FFIE

GLBE

JFBR

JZXN

RERE

The article highlights significant pre-market movements in consumer discretionary stocks on Monday. Faraday Future (FFIE) saw the largest gain, rising by 80.6%, while Jeffs Brands (JFBR) experienced the largest decline, falling by 29.0%. Other notable gainers include Jiuzi Holdings (JZXN) and Global E Online (GLBE), while losers include Barnes & Noble Education (BNED) and ATRenew (RERE).

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 12:07 pm

AIH

AKAN

CPHI

GTBP

HLTH

JAGX

KTRA

PTCT

SXTC

SYRA

TNON

VIRI

The article highlights significant pre-market movements in health care stocks on Monday. GT Biopharma, China Pharma Holdings, Kintara Therapeutics, PTC Therapeutics, China SXT Pharmaceuticals, and Cue Health saw notable gains, while Virios Therapeutics, Jaguar Health, Aesthetic Medical Intl, Akanda, Syra Health, and Tenon Medical experienced declines.

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 12:06 pm

AWIN

HOVR

IPW

MESA

STAF

WLGS

The article highlights the pre-market movements of 12 industrial stocks on Monday. Notable gainers include Mesa Air Group (MESA), iPower (IPW), and Staffing 360 Solutions (STAF), while significant losers include AERWINS Technologies (AWIN), WANG & LEE Group (WLGS), and New Horizon Aircraft (HOVR).

Portfolio Pulse from Benzinga Insights

May 20, 2024 | 12:06 pm